Center For International Blood And Marrow Transplant Research

This trial is testing a stem cell transplant method for people with blood cancers who don't have a perfectly matched donor. It uses stem cells from a partially matched, unrelated donor along with specific medications to prevent complications. The main goal is to see if this appro…

This study is testing if using a lower dose of a standard drug (cyclophosphamide) given after a stem cell transplant can reduce serious infections in the first 100 days. The trial aims to see if this lower dose is just as good at preventing graft-versus-host disease, a common and…

This study is for infants with a severe genetic immune deficiency called SCID. It compares two different, lower doses of chemotherapy given before a stem cell transplant. The goal is to see if a lower dose can help the baby's new immune system develop properly while causing fewer…

This study aims to learn if tracking tiny amounts of leftover leukemia cells in the blood can help doctors predict and understand relapse in patients with acute myeloid leukemia (AML) who have received a stem cell transplant. Researchers will follow 303 adult patients in remissio…